Seattle Genetics - Stock Price History | SGEN

Historical daily share price chart and data for Seattle Genetics since 2020 adjusted for splits. The latest closing stock price for Seattle Genetics as of September 24, 2020 is 179.43.
  • The all-time high Seattle Genetics stock closing price was 184.43 on July 20, 2020.
  • The Seattle Genetics 52-week high stock price is 187.99, which is 4.8% above the current share price.
  • The Seattle Genetics 52-week low stock price is 78.32, which is 56.4% below the current share price.
  • The average Seattle Genetics stock price for the last 52 weeks is 132.35.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Seattle Genetics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 80.2825 57.4900 121.6200 56.3700 114.2600 101.66%
2018 62.0857 56.1300 82.7600 48.1300 56.6600 5.91%
2017 58.8818 53.0000 68.9100 45.9200 53.5000 1.38%
2016 44.8635 41.9200 73.7100 26.8700 52.7700 17.58%
2015 40.5791 32.5400 51.6100 30.5400 44.8800 39.68%
2014 39.8702 40.1800 55.1400 31.1000 32.1300 -19.45%
2013 36.8935 24.1400 48.4800 24.1400 39.8900 72.16%
2012 22.7221 16.4000 29.6750 16.4000 23.1700 38.62%
2011 17.2663 15.5900 22.2800 12.6700 16.7150 11.81%
2010 12.8036 10.5400 17.3500 9.3400 14.9500 47.15%
2009 10.0188 9.1200 14.8000 7.2300 10.1600 13.65%
2008 9.7185 11.3000 12.9700 7.4500 8.9400 -21.58%
2007 9.8390 5.2800 13.1300 5.2800 11.4000 113.88%
2006 4.8641 4.7400 6.2200 3.8200 5.3300 12.92%
2005 5.2173 6.0500 6.4000 3.6400 4.7200 -27.72%
2004 7.4505 9.1000 10.7500 4.7600 6.5300 -23.89%
2003 4.6584 3.2700 8.8500 2.2500 8.5800 176.77%
2002 4.2766 5.6900 6.9100 2.6400 3.1000 -45.61%
2001 6.0685 8.5000 10.3800 3.6500 5.7000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $31.192B $0.917B
Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, ADCETRIS? (brentuximab vedotin) is an ADC that, in collaboration with Takeda Pharmaceutical Company Limited, is commercially available for two indications in more than 45 countries, including the U.S., Canada, Japan and members of the European Union. Additionally, ADCETRIS is being evaluated broadly in more than 30 ongoing clinical trials. Seattle Genetics is also advancing a robust pipeline of clinical-stage ADC programs, including SGN-CD19A, SGN-CD33A, SGN-LIV1A, SGN-CD70A, ASG-22ME and ASG-15ME.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.083B 15.43
Bristol Myers Squibb (BMY) United States $133.476B 10.28
CSL (CSLLY) Australia $94.786B 0.00
Gilead Sciences (GILD) United States $79.097B 11.39
Vertex Pharmaceuticals (VRTX) United States $68.716B 38.35
Regeneron Pharmaceuticals (REGN) United States $60.132B 22.99
Biogen (BIIB) United States $43.093B 7.37
Illumina (ILMN) United States $39.858B 46.35
Moderna (MRNA) United States $26.500B 0.00
BeiGene (BGNE) Cayman Islands $24.831B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.642B 10.27
Genmab (GMAB) Denmark $23.580B 14.90
Genmab (GNMSF) Denmark $21.776B 5.02
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.715B 0.00
Immunomedics (IMMU) United States $19.687B 0.00
Incyte (INCY) United States $18.802B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.471B 38.54
Alnylam Pharmaceuticals (ALNY) United States $15.598B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
BioNTech SE (BNTX) Germany $14.442B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.223B 103.20
ARGENX SE-ADR (ARGX) Netherlands $11.557B 0.00
QIAGEN (QGEN) Netherlands $11.554B 29.32
Sarepta Therapeutics (SRPT) United States $11.302B 0.00
Exact Sciences (EXAS) United States $11.165B 0.00
Guardant Health (GH) United States $10.524B 0.00
Bio-Techne Corp (TECH) United States $9.369B 64.28
Galapagos (GLPG) Belgium $8.942B 32.40
Ascendis Pharma (ASND) Denmark $7.715B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $7.643B 19.01
Repligen (RGEN) United States $7.475B 118.65
Exelixis (EXEL) United States $7.329B 26.65
Mirati Therapeutics (MRTX) United States $7.104B 0.00
MyoKardia (MYOK) United States $6.858B 0.00
Acceleron Pharma (XLRN) United States $6.653B 0.00
Adaptive Biotechnologies (ADPT) United States $6.547B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.378B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.224B 0.00
Novavax (NVAX) United States $6.224B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.943B 184.11
Emergent Biosolutions (EBS) United States $5.411B 21.43
Ultragenyx Pharmaceutical (RARE) United States $5.013B 0.00
Blueprint Medicines (BPMC) United States $4.955B 0.00
Zai Lab (ZLAB) China $4.452B 0.00
China Biologic Products (CBPO) China $4.375B 25.97
Vir Biotechnology (VIR) United States $4.247B 0.00
Arena Pharmaceuticals (ARNA) United States $4.194B 0.00
MorphoSys AG (MOR) Germany $4.164B 54.57
NeoGenomics (NEO) United States $3.814B 1151.33
Denali Therapeutics (DNLI) United States $3.752B 0.00
Legend Biotech (LEGN) United States $3.735B 0.00
Bluebird Bio (BLUE) United States $3.705B 0.00
Reata Pharmaceuticals (RETA) United States $3.650B 0.00
Halozyme Therapeutics (HALO) United States $3.546B 0.00
Amicus Therapeutics (FOLD) United States $3.447B 0.00
Insmed (INSM) United States $3.322B 0.00
Principia Biopharma (PRNB) United States $3.319B 0.00
Global Blood Therapeutics (GBT) United States $3.296B 0.00
Fate Therapeutics (FATE) United States $3.167B 0.00
Twist Bioscience (TWST) United States $2.890B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.874B 0.00
Alkermes (ALKS) Ireland $2.677B 56.10
Inovio Pharmaceuticals (INO) United States $2.675B 0.00
I-Mab (IMAB) China $2.391B 0.00
Sorrento Therapeutics (SRNE) United States $2.323B 0.00
PHARMA MAR SA (PHMMF) Spain $2.208B 0.00
Mesoblast (MESO) Australia $2.059B 0.00
Zymeworks (ZYME) Canada $1.983B 0.00
Editas Medicine (EDIT) United States $1.958B 0.00
Seres Therapeutics (MCRB) United States $1.942B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 21.57
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Intra-Cellular Therapies (ITCI) United States $1.843B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.779B 0.00
Revance Therapeutics (RVNC) United States $1.746B 0.00
Eidos Therapeutics (EIDX) United States $1.699B 0.00
UniQure (QURE) Netherlands $1.688B 0.00
Ligand Pharmaceuticals (LGND) United States $1.498B 50.64
Cytokineticsorporated (CYTK) United States $1.486B 0.00
Amarin (AMRN) Ireland $1.419B 0.00
Viela Bio (VIE) United States $1.411B 0.00
Zealand Pharma (ZEAL) Denmark $1.406B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.404B 0.00
Sangamo Therapeutics (SGMO) United States $1.394B 0.00
Beam Therapeutics (BEAM) United States $1.350B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Coherus BioSciences (CHRS) United States $1.300B 7.58
Mersana Therapeutics (MRSN) United States $1.299B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.289B 0.00
Intellia Therapeutics (NTLA) United States $1.238B 0.00
Epizyme (EPZM) United States $1.212B 0.00
Arcus Biosciences (RCUS) United States $1.146B 0.00
Compugen (CGEN) Israel $1.115B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.094B 0.00
NGM Biopharmaceuticals (NGM) United States $1.073B 0.00
REGENXBIO (RGNX) United States $1.066B 0.00
Athenex (ATNX) United States $1.056B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.034B 0.00
Castle Biosciences (CSTL) United States $0.990B 0.00
Arvinas (ARVN) United States $0.963B 0.00
Alcobra (ARCT) United States $0.950B 0.00
Heska (HSKA) United States $0.921B 0.00
Adverum Biotechnologies (ADVM) United States $0.909B 0.00
Myriad Genetics (MYGN) United States $0.900B 0.00
Retrophin (RTRX) United States $0.900B 0.00
Alector (ALEC) United States $0.889B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.830B 0.00
Vericel (VCEL) United States $0.819B 0.00
Cellectis S.A (CLLS) France $0.798B 0.00
Agenus (AGEN) United States $0.787B 0.00
Pliant Therapeutics (PLRX) United States $0.782B 0.00
Morphic Holding (MORF) United States $0.765B 0.00
NantKwest (NK) United States $0.756B 0.00
Protagonist Therapeutics (PTGX) United States $0.752B 0.00
Pharming Group (PHGUF) Netherlands $0.714B 16.29
MiMedx (MDXG) United States $0.710B 0.00
Codexis (CDXS) United States $0.697B 0.00
VBI Vaccines (VBIV) United States $0.696B 0.00
Frequency Therapeutics (FREQ) United States $0.685B 0.00
Kadmon Holdings (KDMN) United States $0.659B 0.00
Intrexon (PGEN) United States $0.646B 0.00
Cara Therapeutics (CARA) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Northwest Biotherapeutics (NWBO) United States $0.626B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.571B 0.00
Scholar Rock Holding (SRRK) United States $0.532B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.529B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.528B 0.00
Albireo Pharma (ALBO) United States $0.527B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Geron (GERN) United States $0.522B 0.00
Forte Biosciences (FBRX) United States $0.521B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.521B 4.56
Dynavax Technologies (DVAX) United States $0.496B 0.00
Cel-Sci (CVM) United States $0.494B 0.00
Celldex Therapeutics (CLDX) United States $0.479B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.476B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.473B 0.00
Anika Therapeutics (ANIK) United States $0.463B 20.22
MeiraGTx Holdings (MGTX) United States $0.459B 0.00
IVERIC Bio (ISEE) United States $0.452B 0.00
Kala Pharmaceuticals (KALA) United States $0.447B 0.00
Cue Biopharma (CUE) United States $0.447B 0.00
Pfenex (PFNX) United States $0.436B 0.00
MannKind (MNKD) United States $0.429B 0.00
Starpharma Holdings (SPHRY) Australia $0.428B 0.00
Avid Bioservices (CDMO) United States $0.414B 0.00
UROGEN PHARMA (URGN) United States $0.410B 0.00
Syros Pharmaceuticals (SYRS) United States $0.408B 0.00
AnaptysBio (ANAB) United States $0.404B 0.00
Prothena (PRTA) Ireland $0.404B 0.00
Trevena (TRVN) United States $0.387B 0.00
Amryt Pharma (AMYT) United Kingdom $0.386B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.386B 0.00
Puma Biotechnology (PBYI) United States $0.384B 0.00
Athersys (ATHX) United States $0.377B 0.00
BioDelivery Sciences (BDSI) United States $0.374B 26.50
Sutro Biopharma (STRO) United States $0.371B 0.00
Kamada (KMDA) Israel $0.368B 17.60
WAVE Life Sciences (WVE) Singapore $0.365B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.359B 0.00
Cellular Biomedicine (CBMG) United States $0.354B 0.00
IBio (IBIO) United States $0.354B 0.00
Fortress Biotech (FBIO) United States $0.349B 0.00
ANI Pharmaceuticals (ANIP) United States $0.346B 8.18
AC Immune SA (ACIU) Switzerland $0.344B 0.00
PDL BioPharma (PDLI) United States $0.344B 0.00
Merus (MRUS) Netherlands $0.343B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.307B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.306B 0.00
CytomX Therapeutics (CTMX) United States $0.305B 0.00
Innate Pharma S.A (IPHA) France $0.292B 0.00
Precision BioSciences (DTIL) United States $0.274B 0.00
Cardiff Oncology (CRDF) United States $0.264B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.261B 0.00
Selecta Biosciences (SELB) United States $0.260B 0.00
Affimed (AFMD) Germany $0.252B 0.00
ChromaDex (CDXC) United States $0.252B 0.00
OSMOTICA PHARM (OSMT) United States $0.250B 0.00
Prometic Life Sciences (LMNL) Canada $0.249B 0.00
Cyclerion Therapeutics (CYCN) United States $0.247B 0.00
Arbutus Biopharma (ABUS) United States $0.244B 0.00
Pluristem Therapeutics (PSTI) Israel $0.232B 0.00
NextCure (NXTC) United States $0.226B 0.00
TELA Bio (TELA) United States $0.225B 0.00
Verastem (VSTM) United States $0.212B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
XOMA (XOMA) United States $0.201B 0.00
Spero Therapeutics (SPRO) United States $0.199B 0.00
Dyadic (DYAI) United States $0.198B 0.00
Aduro Biotech (ADRO) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Liquidia Technologies (LQDA) United States $0.185B 0.00
ADMA Biologics Inc (ADMA) United States $0.183B 0.00
Kindred Biosciences (KIN) United States $0.183B 0.00
Biofrontera AG (BFRA) Germany $0.182B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.181B 0.00
Eton Pharmaceuticals (ETON) United States $0.181B 0.00
DBV Technologies S.A (DBVT) France $0.179B 0.00
Cerecor (CERC) United States $0.175B 0.00
Theratechnologies (THTX) Canada $0.173B 0.00
Checkpoint Therapeutics (CKPT) United States $0.173B 0.00
CorMedix Inc (CRMD) United States $0.165B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.162B 7.55
Exicure (XCUR) United States $0.161B 0.00
Abeona Therapeutics (ABEO) United States $0.155B 0.00
Aytu Bioscience (AYTU) United States $0.154B 0.00
Aptinyx (APTX) United States $0.152B 0.00
SESEN BIO, INC (SESN) United States $0.151B 0.00
Five Prime Therapeutics (FPRX) United States $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.147B 0.00
GENFIT S.A (GNFT) France $0.146B 0.00
VolitionRX (VNRX) United States $0.145B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.138B 0.00
Bellus Health (BLU) Canada $0.132B 0.00
AquaBounty Technologies (AQB) United States $0.130B 0.00
Celyad SA (CYAD) Belgium $0.129B 0.00
VTv Therapeutics (VTVT) United States $0.129B 0.00
Applied Genetic Technologies (AGTC) United States $0.126B 0.00
Cidara Therapeutics (CDTX) United States $0.125B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Strongbridge Biopharma (SBBP) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.115B 0.00
Protalix BioTherapeutics (PLX) Israel $0.114B 0.00
Lumos Pharma (LUMO) United States $0.113B 0.00
Palatin Technologies (PTN) United States $0.112B 2.88
Pieris Pharmaceuticals (PIRS) United States $0.110B 0.00
Unum Therapeutics (UMRX) United States $0.106B 0.00
Orgenesis (ORGS) United States $0.105B 5.36
Gritstone Oncology (GRTS) United States $0.105B 0.00
Enzo Biochem (ENZ) United States $0.100B 0.00
Antibe Therapeutics (ATBPF) Canada $0.097B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Catalyst Biosciences (CBIO) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.082B 0.00
Oncobiologics (OTLK) United States $0.082B 0.00
Bionano Genomics (BNGO) United States $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.079B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
Evogene (EVGN) Israel $0.075B 0.00
DiaMedica Therapeutics (DMAC) United States $0.074B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.070B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
Curis (CRIS) United States $0.058B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.057B 0.00
Appili Therapeutics (APLIF) Canada $0.056B 0.00
AmpliPhi Biosciences (ARMP) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
TRACON Pharmaceuticals (TCON) United States $0.055B 0.00
Soligenix (SNGX) United States $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.052B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Stealth BioTherapeutics (MITO) United States $0.049B 69.75
Novogen (KZIA) Australia $0.048B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
Genetic Technologies (GENE) Australia $0.044B 0.00
Signal Genetics (MGEN) United States $0.044B 0.00
Organovo Holdings (ONVO) United States $0.041B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Vaccinex (VCNX) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
BioCardia (BCDA) United States $0.030B 0.00
OvaScience (MLND) United States $0.029B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Celsion (CLSN) United States $0.024B 0.00
Acorda Therapeutics (ACOR) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Spherix (AIKI) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.011B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00